Arrowhead Pharmaceuticals - 33 Year Stock Price History | ARWR

Historical daily share price chart and data for Arrowhead Pharmaceuticals since 1993 adjusted for splits and dividends. The latest closing stock price for Arrowhead Pharmaceuticals as of March 05, 2026 is 63.60.

The all-time high Arrowhead Pharmaceuticals stock closing price was 2925.00 on December 16, 1993.
The Arrowhead Pharmaceuticals 52-week high stock price is 76.76, which is 20.7% above the current share price.
The Arrowhead Pharmaceuticals 52-week low stock price is 9.57, which is 85% below the current share price.
The average Arrowhead Pharmaceuticals stock price for the last 52 weeks is 34.01.

Arrowhead Pharmaceuticals Historical Annual Stock Price Data
Year	Average Stock Price	Year Open	Year High	Year Low	Year Close	Annual % Change
2026	65.4858	67.7900	73.0000	61.5500	63.6000	-4.20%
2025	26.0966	19.6500	70.8200	9.9900	66.3900	253.14%
2024	25.3159	31.0100	39.4800	17.7000	18.8000	-38.56%
2023	30.7630	38.5100	41.3800	21.2000	30.6000	-24.56%
2022	40.1287	69.9700	69.9700	27.7900	40.5600	-38.82%
2021	71.2901	74.8300	90.4700	58.0900	66.3000	-13.59%
2020	45.7652	63.1200	85.3700	20.5600	76.7300	20.97%
2019	29.5977	13.1200	73.0100	12.0500	63.4300	410.71%
2018	11.4308	3.7200	20.3000	3.7200	12.4200	237.50%
2017	2.4264	1.6800	4.5000	1.4400	3.6800	137.42%
2016	5.1806	5.9800	8.0800	1.2400	1.5500	-74.80%
2015	6.4723	7.7100	9.0600	4.9000	6.1500	-16.67%
2014	12.7270	10.3100	26.5700	5.0000	7.3800	-31.98%
2013	4.0250	2.1000	11.0700	1.6900	10.8500	407.01%
2012	3.8995	4.1300	7.1400	2.0100	2.1400	-48.93%
2011	5.8726	10.0000	10.0000	3.5870	4.1900	-53.18%
2010	9.9126	5.4000	18.5000	5.1000	8.9500	68.87%
2009	5.7014	10.5000	12.0000	3.1270	5.3000	-42.39%
2008	21.0717	35.5000	35.5000	7.6750	9.2000	-75.66%
2007	48.5855	44.0000	76.0000	33.6000	37.8000	-13.70%
2006	50.3618	40.4000	76.5000	40.4000	43.8000	3.06%
2005	33.0229	40.0000	52.5000	21.4000	42.5000	-1.62%
2004	48.7295	19.5000	84.0000	19.5000	43.2000	232.31%
2003	10.5625	6.5000	26.0000	3.2500	13.0000	233.33%
2002	11.5500	9.7500	52.0000	1.9500	3.9000	-60.00%
2001	25.8065	40.6250	45.5000	9.7500	9.7500	-76.00%
2000	89.7812	97.5000	162.5000	39.0000	40.6250	25.00%
1999	45.5500	52.0000	97.5000	32.5000	32.5000	-37.50%
1998	40.5918	32.5000	78.0000	26.0000	52.0000	60.00%
1997	72.8580	101.5620	142.1880	19.5000	32.5000	-68.00%
1996	270.5089	365.6250	731.2500	81.2500	101.5620	-37.50%
1995	287.7604	60.9375	650.0000	60.9375	162.5000	-80.00%
1994	1169.4196	2112.5000	2193.7500	325.0000	812.5000	-54.55%

Sector	Industry	Market Cap	Revenue
Medical	Medical - Biomedical and Genetics	$8.937B	$0.829B
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company which develops novel drugs to treat intractable diseases primarily in the United States. The company's proprietary Dynamic Polyconjugate platform develops drugs based on the RNA interference mechanism which silences disease-causing genes. Its products include ARC-520, ARC-521, ARC-AAT, ARC-F12, ARC-HIF2 and ARC-LPA which are in different clinical trial phase. Arrowhead Pharmaceuticals, Inc., formerly known as Arrowhead Research Corporation, is headquartered in Pasadena, California.

Stock Name	Country	Market Cap	PE Ratio
AstraZeneca (AZN)	United Kingdom	$318.789B	25.38
Amgen (AMGN)	United States	$198.802B	16.90
Gilead Sciences (GILD)	United States	$192.281B	19.02
Vertex Pharmaceuticals (VRTX)	United States	$124.695B	29.93
Bristol Myers Squibb (BMY)	United States	$123.695B	9.88
GSK (GSK)	United Kingdom	$120.123B	13.04
Regeneron Pharmaceuticals (REGN)	United States	$84.911B	22.26
CSL (CSLLY)	Australia	$51.426B	0.00
Argenex SE (ARGX)	Netherlands	$50.866B	62.84
Alnylam Pharmaceuticals (ALNY)	United States	$41.697B	184.94
Insmed (INSM)	United States	$31.724B	0.00
Biogen (BIIB)	United States	$28.841B	12.85
Royalty Pharma (RPRX)	United States	$26.085B	9.36
BioNTech SE (BNTX)	Germany	$23.840B	0.00
Incyte (INCY)	United States	$20.120B	17.46
Exact Sciences (EXAS)	United States	$19.699B	2581.00
Genmab (GMAB)	Denmark	$19.291B	14.51
Roivant Sciences (ROIV)	United Kingdom	$18.930B	0.00
Revolution Medicines (RVMD)	United States	$18.619B	0.00
Illumina (ILMN)	United States	$17.860B	24.08
Moderna (MRNA)	United States	$16.501B	0.00
Sino Biopharmaceutical (SBMFF)	Hong Kong, SAR China	$15.757B	0.00
Regencell Bioscience Holdings (RGC)	Hong Kong, SAR China	$15.438B	0.00
Ascendis Pharma (ASND)	Denmark	$13.407B	0.00
Guardant Health (GH)	United States	$13.215B	0.00
Swedish Orphan Biovitrum (BIOVF)	Sweden	$13.172B	21.26
BioMarin Pharmaceutical (BMRN)	United States	$11.502B	20.86
Exelixis (EXEL)	United States	$11.406B	16.09
Avidity Biosciences (RNA)	United States	$11.276B	0.00
QIAGEN (QGEN)	Netherlands	$10.645B	20.39
Jazz Pharmaceuticals (JAZZ)	Ireland	$10.106B	39.41
Abivax SA (ABVX)	France	$9.883B	0.00
Bio-Techne Corp (TECH)	United States	$9.376B	34.05
Halozyme Therapeutics (HALO)	United States	$9.342B	14.93
Axsome Therapeutics (AXSM)	United States	$9.135B	0.00
Cytokinetics (CYTK)	United States	$8.101B	0.00
Krystal Biotech (KRYS)	United States	$8.016B	41.45
Praxis Precision Medicines (PRAX)	United States	$7.993B	0.00
Repligen (RGEN)	United States	$7.680B	82.19
Nuvalent (NUVL)	United States	$7.330B	0.00
Vaxcyte (PCVX)	United States	$7.082B	0.00
Cidara Therapeutics (CDTX)	United States	$6.960B	0.00
Bio-Rad Laboratories (BIO.B)	United States	$6.934B	25.91
Merus (MRUS)	Netherlands	$6.826B	0.00
Belite Bio (BLTE)	United States	$6.575B	0.00
Rhythm Pharmaceuticals (RYTM)	United States	$6.545B	0.00
Kymera Therapeutics (KYMR)	United States	$5.924B	0.00
ImmunityBio (IBRX)	United States	$5.856B	0.00
PTC Therapeutics (PTCT)	United States	$5.576B	7.57
Alkermes (ALKS)	Ireland	$5.475B	16.10
Mirum Pharmaceuticals (MIRM)	United States	$5.299B	0.00
Immunovant (IMVT)	United States	$5.241B	0.00
Cogent Biosciences (COGT)	United States	$5.201B	0.00
Protagonist Therapeutics (PTGX)	United States	$5.094B	131.44
CRISPR Therapeutics AG (CRSP)	Switzerland	$5.094B	0.00
Celcuity (CELC)	United States	$4.836B	0.00
Scholar Rock Holding (SRRK)	United States	$4.690B	0.00
Apogee Therapeutics (APGE)	United States	$4.631B	0.00
Zealand Pharma (ZLDPF)	Denmark	$4.534B	4.59
TG Therapeutics (TGTX)	United States	$4.525B	10.25
Akero Therapeutics (AKRO)	United States	$4.499B	0.00
Amicus Therapeutics (FOLD)	United States	$4.492B	357.75
Structure Therapeutics (GPCR)	United States	$4.252B	0.00
CG Oncology (CGON)	United States	$4.154B	0.00
Arcellx (ACLX)	United States	$3.961B	0.00
Terns Pharmaceuticals (TERN)	United States	$3.921B	0.00
ADMA Biologics Inc (ADMA)	United States	$3.829B	27.27
GRAIL (GRAL)	United States	$3.801B	0.00
ACADIA Pharmaceuticals (ACAD)	United States	$3.727B	31.47
Erasca (ERAS)	United States	$3.715B	0.00
Ligand Pharmaceuticals (LGND)	United States	$3.618B	88.81
Anbio Biotechnology (NNNN)	Germany	$3.482B	0.00
Kiniksa Pharmaceuticals (KNSA)	United Kingdom	$3.439B	100.82
Viking Therapeutics (VKTX)	United States	$3.351B	0.00
Liquidia (LQDA)	United States	$3.323B	0.00
Legend Biotech (LEGN)	United States	$3.247B	0.00
Xenon Pharmaceuticals (XENE)	Canada	$3.205B	0.00
Edgewise Therapeutics (EWTX)	United States	$3.177B	0.00
Arcutis Biotherapeutics (ARQT)	United States	$3.168B	0.00
Twist Bioscience (TWST)	United States	$3.011B	0.00
Vera Therapeutics (VERA)	United States	$2.957B	0.00
Spyre Therapeutics (SYRE)	United States	$2.842B	0.00
Beam Therapeutics (BEAM)	United States	$2.833B	0.00
Alumis (ALMS)	United States	$2.771B	0.00
Denali Therapeutics (DNLI)	United States	$2.753B	0.00
Apellis Pharmaceuticals (APLS)	United States	$2.746B	70.00
Viridian Therapeutics (VRDN)	United States	$2.663B	0.00
IDEAYA Biosciences (IDYA)	United States	$2.654B	0.00
Tarsus Pharmaceuticals (TARS)	United States	$2.580B	0.00
HUTCHMED (China) (HCM)	Hong Kong, SAR China	$2.575B	0.00
Travere Therapeutics (TVTX)	United States	$2.489B	0.00
Adaptive Biotechnologies (ADPT)	United States	$2.449B	0.00
Immunome (IMNM)	United States	$2.445B	0.00
Bavarian Nordic (BVNRY)	Denmark	$2.389B	6.48
Zai Lab (ZLAB)	China	$2.260B	0.00
Ascentage Pharma Group - (AAPG)	China	$2.223B	0.00
Telix Pharmaceuticals (TLX)	Australia	$2.216B	0.00
Maze Therapeutics (MAZE)	United States	$2.214B	0.00
Mineralys Therapeutics (MLYS)	United States	$2.184B	0.00
Mesoblast (MESO)	Australia	$2.151B	0.00
WAVE Life Sciences (WVE)	Singapore	$2.120B	0.00
Disc Medicine (IRON)	United States	$2.112B	0.00
Harmony Biosciences Holdings (HRMY)	United States	$2.074B	11.32
Dianthus Therapeutics (DNTH)	United States	$2.049B	0.00
Arcus Biosciences (RCUS)	United States	$2.043B	0.00
Ultragenyx Pharmaceutical (RARE)	United States	$1.980B	0.00
Nuvation Bio (NUVB)	United States	$1.978B	0.00
Sarepta Therapeutics (SRPT)	United States	$1.864B	0.00
Stoke Therapeutics (STOK)	United States	$1.823B	47.63
Dynavax Technologies (DVAX)	United States	$1.819B	53.41
Vericel (VCEL)	United States	$1.819B	149.83
Recursion Pharmaceuticals (RXRX)	United States	$1.814B	0.00
Syndax Pharmaceuticals (SNDX)	United States	$1.780B	0.00
Precigen (PGEN)	United States	$1.744B	0.00
ANI Pharmaceuticals (ANIP)	United States	$1.738B	13.48
MannKind (MNKD)	United States	$1.738B	56.60
Tango Therapeutics (TNGX)	United States	$1.737B	0.00
MBX Biosciences (MBX)	United States	$1.710B	0.00
Zymeworks (ZYME)	United States	$1.691B	0.00
Sionna Therapeutics (SION)	United States	$1.674B	0.00
Agios Pharmaceuticals (AGIO)	United States	$1.638B	0.00
Immunocore Holdings (IMCR)	United Kingdom	$1.631B	0.00
Nurix Therapeutics (NRIX)	United States	$1.604B	0.00
Rapt Therapeutics (RAPT)	United States	$1.599B	0.00
Corvus Pharmaceuticals (CRVS)	United States	$1.563B	0.00
Olema Pharmaceuticals (OLMA)	United States	$1.551B	0.00
Celldex Therapeutics (CLDX)	United States	$1.528B	0.00
Tyra Biosciences (TYRA)	United States	$1.494B	0.00
Oculis Holding AG (OCS)	Switzerland	$1.492B	0.00
Mind Medicine (MindMed) (MNMD)	United States	$1.480B	0.00
NeoGenomics (NEO)	United States	$1.472B	0.00
AnaptysBio (ANAB)	United States	$1.470B	0.00
Zenas BioPharma (ZBIO)	United States	$1.417B	0.00
Novavax (NVAX)	United States	$1.414B	3.60
Alvotech (ALVO)	Luxembourg	$1.399B	20.17
Intellia Therapeutics (NTLA)	United States	$1.375B	0.00
Trevi Therapeutics (TRVI)	United States	$1.334B	0.00
Rapport Therapeutics (RAPP)	United States	$1.331B	0.00
AtaiBeckley Inc (ATAI)	Netherlands	$1.297B	0.00
UniQure (QURE)	Netherlands	$1.277B	0.00
Septerna (SEPN)	United States	$1.231B	0.00
NovoCure (NVCR)	Jersey	$1.231B	0.00
Nanobiotix S.A - (NBTX)	France	$1.226B	0.00
Biohaven (BHVN)	United States	$1.203B	0.00
Oxford BioMedica (OXBDF)	United Kingdom	$1.202B	0.00
Immatics (IMTX)	Germany	$1.196B	0.00
Kodiak Sciences (KOD)	United States	$1.171B	0.00
Monte Rosa Therapeutics (GLUE)	United States	$1.167B	56.00
Day One Biopharmaceuticals (DAWN)	United States	$1.165B	0.00
Compass Therapeutics (CMPX)	United States	$1.117B	0.00
Inhibrx Biosciences (INBX)	United States	$1.102B	0.00
Pharming Group (PHAR)	Netherlands	$1.082B	0.00
EyePoint (EYPT)	United States	$1.071B	0.00
Certara (CERT)	United States	$1.054B	19.47
Geron (GERN)	United States	$1.053B	0.00
Vir Biotechnology (VIR)	United States	$1.039B	0.00
Sana Biotechnology (SANA)	United States	$1.026B	0.00
Iovance Biotherapeutics (IOVA)	United States	$1.020B	0.00
MoonLake Immunotherapeutics (MLTX)	Switzerland	$1.013B	0.00
Ventyx Biosciences (VTYX)	United States	$1.003B	0.00
Evommune (EVMN)	United States	$0.995B	0.00
Oric Pharmaceuticals (ORIC)	United States	$0.973B	0.00
Castle Biosciences (CSTL)	United States	$0.968B	132.60
Palvella Therapeutics (PVLA)	United States	$0.965B	0.00
Urogen Pharma (URGN)	United States	$0.941B	0.00
Pacira BioSciences (PCRX)	United States	$0.937B	10.72
Basilea Pharmaceutica AG (BPMUF)	Switzerland	$0.935B	0.00
AbCellera Biologics (ABCL)	Canada	$0.928B	0.00
ArriVent BioPharma (AVBP)	United States	$0.927B	0.00
CureVac (CVAC)	Germany	$0.927B	0.00
Fortrea Holdings (FTRE)	United States	$0.905B	19.20
CytomX Therapeutics (CTMX)	United States	$0.901B	13.30
Inventiva S.A (IVA)	France	$0.901B	0.00
BridgeBio Oncology Therapeutics (BBOT)	United States	$0.900B	0.00
Phathom Pharmaceuticals (PHAT)	United States	$0.858B	0.00
DBV Technologies S.A (DBVT)	France	$0.839B	0.00
Janux Therapeutics (JANX)	United States	$0.790B	0.00
MapLight Therapeutics (MPLT)	United States	$0.781B	0.00
Bicara Therapeutics (BCAX)	United States	$0.778B	0.00
Gyre Therapeutics (GYRE)	United States	$0.773B	100.25
Arbutus Biopharma (ABUS)	United States	$0.765B	0.00
GH Research (GHRS)	Ireland	$0.765B	0.00
MiMedx (MDXG)	United States	$0.758B	13.47
Bright Minds Biosciences (DRUG)	United States	$0.758B	0.00
Arvinas (ARVN)	United States	$0.748B	0.00
Jade Biosciences (JBIO)	United States	$0.741B	0.00
Kura Oncology (KURA)	United States	$0.723B	0.00
Astria Therapeutics (ATXS)	United States	$0.718B	0.00
BioAge Labs (BIOA)	United States	$0.702B	0.00
YD Bio (YDES)		$0.694B	0.00
Cullinan Therapeutics (CGEM)	United States	$0.685B	0.00
Replimune (REPL)	United States	$0.658B	0.00
EnGene Holdings (ENGN)	Canada	$0.655B	0.00
Sinovac Biotech (SVA)	China	$0.645B	0.00
MeiraGTx Holdings (MGTX)	United States	$0.600B	0.00
Prime Medicine (PRME)	United States	$0.596B	0.00
LB Pharmaceuticals Inc (LBRX)	United States	$0.590B	0.00
Annexon (ANNX)	United States	$0.585B	0.00
CorMedix Inc (CRMD)	United States	$0.578B	5.36
Fulcrum Therapeutics (FULC)	United States	$0.575B	0.00
Design Therapeutics (DSGN)	United States	$0.574B	0.00
Emergent Biosolutions (EBS)	United States	$0.569B	5.47
Ginkgo Bioworks Holdings (DNA)	United States	$0.563B	0.00
Cytek Biosciences (CTKB)	United States	$0.542B	0.00
Neumora Therapeutics (NMRA)	United States	$0.535B	0.00
Gossamer Bio (GOSS)	United States	$0.530B	0.00
Alto Neuroscience (ANRO)	United States	$0.525B	0.00
SELLAS Life Sciences (SLS)	United States	$0.511B	0.00
Keros Therapeutics (KROS)	United States	$0.505B	10.77
ADC Therapeutics SA (ADCT)	Switzerland	$0.494B	0.00
Kamada (KMDA)	Israel	$0.489B	23.61
Prothena (PRTA)	Ireland	$0.482B	0.00
Solid Biosciences (SLDB)	United States	$0.482B	0.00
Lexicon Pharmaceuticals (LXRX)	United States	$0.476B	0.00
Upstream Bio (UPB)	United States	$0.473B	0.00
Eton Pharmaceuticals (ETON)	United States	$0.458B	0.00
DiaMedica Therapeutics (DMAC)	United States	$0.444B	0.00
PepGen (PEPG)	United States	$0.443B	0.00
Ocugen (OCGN)	United States	$0.440B	0.00
PureTech Health (PRTC)	United States	$0.422B	0.00
Contineum Therapeutics (CTNM)	United States	$0.421B	0.00
Myriad Genetics (MYGN)	United States	$0.419B	0.00
Tectonic Therapeutic (TECX)	United States	$0.417B	0.00
Entrada Therapeutics (TRDA)	United States	$0.416B	0.00
Niagen Bioscience (NAGE)	United States	$0.410B	32.12
Allogene Therapeutics (ALLO)	United States	$0.405B	0.00
REGENXBIO (RGNX)	United States	$0.404B	0.00
LENZ Therapeutics (LENZ)	United States	$0.403B	0.00
Forte Biosciences (FBRX)	United States	$0.402B	0.00
Enanta Pharmaceuticals (ENTA)	United States	$0.402B	0.00
Zura Bio (ZURA)	United States	$0.395B	0.00
GENFIT S.A (GNFTY)	France	$0.391B	0.00
Prima BioMed (IMMP)	Australia	$0.389B	0.00
Verastem (VSTM)	United States	$0.389B	0.00
Immix Biopharma (IMMX)	United States	$0.388B	0.00
Climb Bio (CLYM)	United States	$0.387B	0.00
Absci (ABSI)	United States	$0.383B	0.00
Northwest Biotherapeutics (NWBO)	United States	$0.383B	0.00
Autolus Therapeutics (AUTL)	United Kingdom	$0.373B	0.00
Greenwich LifeSciences (GLSI)	United States	$0.372B	0.00
Monopar Therapeutics (MNPR)	United States	$0.371B	0.00
NovaBridge Biosciences (NBP)	United States	$0.370B	0.00
Prenetics Global (PRE)	Hong Kong, SAR China	$0.370B	0.00
Rezolute (RZLT)	United States	$0.367B	0.00
Anavex Life Sciences (AVXL)	United States	$0.364B	0.00
Invivyd (IVVD)	United States	$0.364B	0.00
Bicycle Therapeutics (BCYC)	United Kingdom	$0.363B	0.00
Vanda Pharmaceuticals (VNDA)	United States	$0.360B	0.00
Benitec Biopharma (BNTC)	United States	$0.357B	0.00
Rocket Pharmaceuticals (RCKT)	United States	$0.354B	0.00
Aura Biosciences (AURA)	United States	$0.354B	0.00
Adlai Nortye (ANL)	Cayman Islands	$0.351B	0.00
Puma Biotechnology (PBYI)	United States	$0.344B	9.22
Atea Pharmaceuticals (AVIR)	United States	$0.337B	0.00
Immuneering (IMRX)	United States	$0.318B	0.00
Kyverna Therapeutics (KYTX)	United States	$0.318B	0.00
Foghorn Therapeutics (FHTX)	United States	$0.314B	0.00
Candel Therapeutics (CADL)	United States	$0.312B	0.00
Amarin (AMRN)	Ireland	$0.306B	0.00
Eupraxia Pharmaceuticals (EPRX)	Canada	$0.303B	0.00
AC Immune (ACIU)	Switzerland	$0.300B	0.00
X4 Pharmaceuticals (XFOR)	United States	$0.298B	0.00
XOMA Royalty (XOMA)	United States	$0.297B	0.00
Adherex Technologies (FENC)	United States	$0.288B	0.00
Nautilus Biotechnology (NAUT)	United States	$0.277B	0.00
Abeona Therapeutics (ABEO)	United States	$0.272B	4.43
Cabaletta Bio (CABA)	United States	$0.270B	0.00
Neurogene (NGNE)	United States	$0.269B	0.00
Lifecore Biomedical (LFCR)	United States	$0.265B	0.00
Aardvark Therapeutics (AARD)	United States	$0.263B	0.00
Palisade Bio (PALI)	United States	$0.258B	0.00
Opus Genetics (IRD)	United States	$0.251B	0.00
Shattuck Labs (STTK)	United States	$0.244B	0.00
Nuvectis Pharma (NVCT)	United States	$0.232B	0.00
Adocia (ADOCY)	France	$0.231B	0.00
Orchestra BioMed Holdings (OBIO)	United States	$0.216B	0.00
Arcturus Therapeutics Holdings (ARCT)	United States	$0.205B	0.00
Alector (ALEC)	United States	$0.204B	0.00
Coherus Oncology (CHRS)	United States	$0.195B	0.00
Humacyte (HUMA)	United States	$0.189B	0.00
Voyager Therapeutics (VYGR)	United States	$0.188B	0.00
Molecular Partners AG (MOLN)	Switzerland	$0.186B	0.00
SAB Biotherapeutics (SABS)	United States	$0.183B	0.00
C4 Therapeutics (CCCC)	United States	$0.183B	0.00
CAMP4 Therapeutics (CAMP)	United States	$0.180B	0.00
Satellos Bioscience (MSLE)	Canada	$0.178B	0.00
Tiziana Life Sciences (TLSA)	United Kingdom	$0.177B	0.00
Zentalis Pharmaceuticals (ZNTL)	United States	$0.173B	0.00
Editas Medicine (EDIT)	United States	$0.172B	0.00
Cartesian Therapeutics (RNAC)	United States	$0.170B	0.00
Tharimmune (THAR)	United States	$0.169B	0.00
Sagimet Biosciences (SGMT)	United States	$0.165B	0.00
Innate Pharma S.A (IPHA)	France	$0.163B	0.00
Kalaris Therapeutics (KLRS)	United States	$0.162B	0.00
ProQR Therapeutics (PRQR)	Netherlands	$0.154B	0.00
Adagene (ADAG)	China	$0.153B	0.00
Acumen Pharmaceuticals (ABOS)	United States	$0.152B	0.00
Rani Therapeutics Holdings (RANI)	United States	$0.151B	0.00
Alps Group (ALPS)	United States	$0.150B	2.73
Elicio Therapeutics (ELTX)	United States	$0.150B	0.00
Starpharma Holdings (SPHRY)	Australia	$0.149B	0.00
Caribou Biosciences (CRBU)	United States	$0.148B	0.00
Anika Therapeutics (ANIK)	United States	$0.147B	0.00
Mersana Therapeutics (MRSN)	United States	$0.145B	0.00
Connect Biopharma Holdings (CNTB)	United States	$0.145B	0.00
Milestone Pharmaceuticals (MIST)	Canada	$0.145B	0.00
Fate Therapeutics (FATE)	United States	$0.144B	0.00
Nkarta (NKTX)	United States	$0.140B	0.00
Sutro Biopharma (STRO)	United States	$0.138B	0.00
Spero Therapeutics (SPRO)	United States	$0.135B	0.00
Whitehawk Therapeutics (WHWK)	United States	$0.134B	0.00
VTv Therapeutics (VTVT)	United States	$0.133B	0.00
Vor Biopharma (VOR)		$0.133B	0.00
Sangamo Therapeutics (SGMO)	United States	$0.130B	0.00
Black Diamond Therapeutics (BDTX)	United States	$0.126B	6.17
Crescent Biopharma (CBIO)	United States	$0.124B	0.00
Eledon Pharmaceuticals (ELDN)	United States	$0.121B	0.00
ALX Oncology Holdings (ALXO)	United States	$0.120B	0.00
Jyong Biotech (MENS)	Taiwan	$0.118B	0.00
Repare Therapeutics (RPTX)	Canada	$0.114B	0.00
Seer (SEER)	United States	$0.113B	0.00
Oncolytics Biotech (ONCY)	Canada	$0.113B	0.00
Fortress Biotech (FBIO)	United States	$0.112B	0.00
Immunic (IMUX)	United States	$0.110B	0.00
Codexis (CDXS)	United States	$0.108B	0.00
Tenaya Therapeutics (TNYA)	United States	$0.108B	0.00
Cardiff Oncology (CRDF)	United States	$0.108B	0.00
Citius Oncology (CTOR)	United States	$0.108B	0.00
Inovio Pharmaceuticals (INO)	United States	$0.107B	0.00
Alpha Teknova (TKNO)	United States	$0.107B	0.00
BGM Group (BGM)	China	$0.107B	0.00
Alpha Cognition (ACOG)	Canada	$0.106B	0.00
Turn Therapeutics (TTRX)	United States	$0.103B	0.00
Ovid Therapeutics (OVID)	United States	$0.101B	0.00
Actuate Therapeutics (ACTU)	United States	$0.101B	0.00
Genelux (GNLX)	United States	$0.099B	0.00
Agenus (AGEN)	United States	$0.099B	0.00
Cognition Therapeutics (CGTX)	United States	$0.099B	0.00
Coya Therapeutics (COYA)	United States	$0.099B	0.00
Artiva Biotherapeutics (ARTV)	United States	$0.098B	0.00
BioStem Technologies (BSEM)		$0.098B	6.82
Chrome Holding (MEHCQ)	United States	$0.096B	0.00
Adverum Biotechnologies (ADVM)	United States	$0.096B	0.00
Equillium (EQ)	United States	$0.096B	0.00
ANIXA BIOSCIENCES INC (ANIX)	United States	$0.094B	0.00
Precision BioSciences (DTIL)	United States	$0.089B	0.00
Biomea Fusion (BMEA)	United States	$0.088B	0.00
ATyr Pharma (ATYR)	United States	$0.088B	0.00
EXoZymes (EXOZ)	United States	$0.086B	0.00
TuHURA Biosciences (HURA)	United States	$0.081B	0.00
Tenax Therapeutics (TENX)	United States	$0.079B	0.00
BioHarvest Sciences (BHST)	Canada	$0.078B	0.00
ImageneBio (IMA)	United States	$0.077B	0.00
MaxCyte (MXCT)	United States	$0.077B	0.00
IBio (IBIO)	United States	$0.077B	0.00
Seres Therapeutics (MCRB)	United States	$0.077B	0.00
XBiotech (XBIT)	United States	$0.075B	0.00
MediciNova (MNOV)	United States	$0.073B	0.00
OKYO Pharma (OKYO)		$0.071B	0.00
Spruce Biosciences (SPRB)	United States	$0.071B	0.00
Scilex Holding (SCLX)	United States	$0.071B	0.00
Entera Bio (ENTX)	Israel	$0.069B	0.00
Pliant Therapeutics (PLRX)	United States	$0.068B	0.00
Adicet Bio (ACET)	United States	$0.066B	0.00
Coeptis Therapeutics Holdings (COEP)	United States	$0.065B	0.00
Annovis Bio (ANVS)	United States	$0.063B	0.00
Mereo BioPharma Group - (MREO)	United Kingdom	$0.059B	0.00
Radiopharm Theranostics - (RADX)	Australia	$0.058B	0.00
InflaRx (IFRX)	Germany	$0.058B	0.00
Grace Therapeutics (GRCE)	United States	$0.056B	0.00
Tevogen Bio Holdings (TVGN)	United States	$0.056B	0.00
Instil Bio (TIL)	United States	$0.054B	0.00
TScan Therapeutics (TCRX)	United States	$0.053B	0.00
MiNK Therapeutics (INKT)	United States	$0.052B	0.00
BeyondSpring (BYSI)	United States	$0.051B	0.00
MIRA Pharmaceuticals (MIRA)	United States	$0.049B	0.00
Q32 Bio (QTTB)	United States	$0.048B	0.00
Estrella Immunopharma (ESLA)	United States	$0.048B	0.00
Galecto (GLTO)	Denmark	$0.047B	0.00
Kezar Life Sciences (KZR)	United States	$0.046B	0.00
NextCure (NXTC)	United States	$0.046B	0.00
Clene (CLNN)	United States	$0.046B	0.00
Zhengye Biotechnology Holding (ZYBT)	China	$0.045B	0.00
Elutia (ELUT)	United States	$0.045B	0.00
Cingulate (CING)	United States	$0.045B	0.00
CervoMed (CRVO)	United States	$0.044B	0.00
Aligos Therapeutics (ALGS)	United States	$0.043B	0.00
ABVC BioPharma (ABVC)	United States	$0.042B	0.00
Lisata Therapeutics (LSTA)	United States	$0.040B	0.00
Xilio Therapeutics (XLO)	United States	$0.039B	0.00
INmune Bio (INMB)	United States	$0.038B	0.00
Generation Bio (GBIO)	United States	$0.038B	0.00
Celularity (CELU)	United States	$0.036B	0.00
Oncobiologics (OTLK)	United States	$0.036B	0.00
Pluri (PLUR)	Israel	$0.036B	0.00
Tvardi Therapeutics (TVRD)	United States	$0.035B	0.00
BioXcel Therapeutics (BTAI)	United States	$0.035B	0.00
PDS Biotechnology (PDSB)	United States	$0.034B	0.00
RenovoRx (RNXT)	United States	$0.034B	0.00
Hyperion DeFi (HYPD)	United States	$0.034B	0.00
Promis Neurosciences (PMN)	Canada	$0.033B	0.00
OnKure Therapeutics (OKUR)	United States	$0.033B	0.00
Atara Biotherapeutics (ATRA)	United States	$0.032B	2.04
Jasper Therapeutics (JSPR)	United States	$0.032B	0.00
TELA Bio (TELA)	United States	$0.032B	0.00
Werewolf Therapeutics (HOWL)	United States	$0.032B	0.00
Alterity Therapeutics - (ATHE)	Australia	$0.031B	0.00
Lantern Pharma (LTRN)	United States	$0.030B	0.00
Kyntra Bio Inc (KYNB)	United States	$0.030B	0.00
Dyadic (DYAI)	United States	$0.030B	0.00
Femasys (FEMY)	United States	$0.030B	0.00
BRIACELL THERAP (BCTX)	Canada	$0.030B	0.00
Rein Therapeutics (RNTX)	United States	$0.029B	0.00
AN2 Therapeutics (ANTX)	United States	$0.029B	0.00
Passage Bio (PASG)	United States	$0.028B	0.00
Medicus Pharma (MDCX)	United States	$0.027B	0.00
Athira Pharma (ATHA)	United States	$0.027B	0.00
IO Biotech (IOBT)	Denmark	$0.027B	0.00
Exicure (XCUR)	United States	$0.026B	0.00
Barinthus Biotherapeutics (BRNS)	United States	$0.026B	0.00
Rallybio (RLYB)	United States	$0.025B	0.00
Boundless Bio (BOLD)	United States	$0.025B	0.00
Dare Bioscience (DARE)	United States	$0.024B	0.00
Cue Biopharma (CUE)	United States	$0.024B	0.00
Skye Bioscience (SKYE)	United States	$0.023B	0.00
Aytu BioPharma (AYTU)	United States	$0.023B	0.00
Lixte Biotechnology Holdings (LIXT)	United States	$0.023B	0.00
Senti Biosciences (SNTI)	United States	$0.022B	0.00
Apollomics (APLM)	United States	$0.022B	0.00
Neuphoria Therapeutics (NEUP)	United States	$0.022B	0.00
VistaGen Therapeutics (VTGN)	United States	$0.020B	0.00
Anebulo Pharmaceuticals (ANEB)	United States	$0.020B	0.00
IN8bio (INAB)	United States	$0.017B	0.00
LeonaBio (LONA)	United States	$0.017B	0.00
Genenta Science S.p.A (GNTA)	Italy	$0.017B	0.00
FibroBiologics (FBLG)	United States	$0.017B	0.00
Pasithea Therapeutics (KTTA)	United States	$0.016B	0.00
Intensity Therapeutics (INTS)	United States	$0.016B	0.00
Hoth Therapeutics (HOTH)	United States	$0.016B	0.00
Curis (CRIS)	United States	$0.016B	0.00
Black Titan (BTTC)	United States	$0.016B	0.00
Lexaria Bioscience (LEXX)	Canada	$0.015B	0.00
Polyrizon (PLRZ)	Israel	$0.014B	0.00
Applied Therapeutics (APLT)	United States	$0.014B	0.00
Quantum Biopharma (QNTM)	Canada	$0.014B	0.00
Allarity Therapeutics (ALLR)	United States	$0.014B	0.00
Cocrystal Pharma (COCP)	United States	$0.013B	0.00
Cadrenal Therapeutics (CVKD)	United States	$0.013B	0.00
NewcelX (NCEL)	Switzerland	$0.013B	0.00
BioCardia (BCDA)	United States	$0.012B	0.00
Sensei Biotherapeutics (SNSE)	United States	$0.011B	0.00
Longeveron (LGVN)	United States	$0.011B	0.00
Bionano Genomics (BNGO)	United States	$0.011B	0.00
Quince Therapeutics (QNCX)	United States	$0.011B	0.00
Soligenix (SNGX)	United States	$0.011B	0.00
Akari Therapeutics (AKTX)	United Kingdom	$0.011B	0.00
Revelation Biosciences (REVB)	United States	$0.010B	0.00
Imunon (IMNN)	United States	$0.010B	0.00
BioAtla (BCAB)	United States	$0.010B	0.00
Bolt Biotherapeutics (BOLT)	United States	$0.010B	0.00
CalciMedica (CALC)	United States	$0.009B	0.00
Chemomab Therapeutics (CMMB)	Israel	$0.009B	0.00
CollPlant Biotechnologies (CLGN)	Israel	$0.009B	0.00
Biofrontera (BFRI)	United States	$0.009B	0.00
Cuprina Holdings (Cayman) (CUPR)	Singapore	$0.009B	0.00
Moleculin Biotech (MBRX)	United States	$0.009B	0.00
Edesa Biotech (EDSA)	Canada	$0.009B	0.00
Beyond Air (XAIR)	United States	$0.008B	0.00
Novogen (KZIA)	Australia	$0.008B	0.00
Gelteq (GELS)	Australia	$0.008B	0.00
Purple Biotech (PPBT)	Israel	$0.007B	0.00
Mainz Biomed (MYNZ)	Germany	$0.007B	0.00
Dogwood Therapeutics (DWTX)	United States	$0.007B	0.00
Aptevo Therapeutics (APVO)	United States	$0.007B	0.00
Mustang Bio (MBIO)	United States	$0.006B	0.00
GENPREX (GNPX)	United States	$0.006B	0.00
Alzamend Neuro (ALZN)	United States	$0.006B	0.00
IMMURON (IMRN)	Australia	$0.006B	0.00
Sunshine Biopharma (SBFM)	United States	$0.006B	0.00
VivoSim Labs (VIVS)	United States	$0.005B	0.00
Advanced Biomed (ADVB)	United States	$0.005B	1.20
Evogene (EVGN)	Israel	$0.005B	0.00
Acurx Pharmaceuticals (ACXP)	United States	$0.005B	0.00
Silexion Therapeutics Corp (SLXN)	Israel	$0.005B	0.00
GT Biopharma (GTBP)	United States	$0.005B	0.00
Cyclerion Therapeutics (CYCN)	United States	$0.005B	0.00
Creative Medical Technology Holdings (CELZ)	United States	$0.005B	0.00
Decoy Therapeutics Inc (DCOY)	United States	$0.005B	0.00
BioAffinity Technologies (BIAF)	United States	$0.005B	0.00
Aprea Therapeutics (APRE)	United States	$0.004B	0.00
KALA BIO (KALA)	United States	$0.004B	0.00
Silo Pharma (SILO)	United States	$0.004B	0.00
Aspire Biopharma Holdings (ASBP)	United States	$0.004B	0.00
Avalon GloboCare (ALBT)	United States	$0.004B	0.00
Dermata Therapeutics (DRMA)	United States	$0.004B	0.00
MetaVia (MTVA)	United States	$0.004B	0.00
AquaBounty Technologies (AQB)	United States	$0.003B	0.00
GRI Bio (GRI)	United States	$0.003B	0.00
Propanc Biopharma Inc (PPCB)	Australia	$0.003B	0.00
Adial Pharmaceuticals (ADIL)	United States	$0.003B	0.00
Psyence Biomedical (PBM)	Canada	$0.003B	0.00
Enveric Biosciences (ENVB)	United States	$0.003B	0.00
GeoVax Labs (GOVX)	United States	$0.003B	0.00
Arcadia Biosciences (RKDA)	United States	$0.003B	0.00
Biorestorative Therapies (BRTX)	United States	$0.003B	0.00
Artelo Biosciences (ARTL)	United States	$0.002B	0.00
Scinai Immunotherapeutics (SCNI)	Israel	$0.002B	0.00
Cardio Diagnostics Holdings (CDIO)	United States	$0.002B	0.00
CNS Pharmaceuticals (CNSP)	United States	$0.002B	0.00
Bone Biologics (BBLG)	United States	$0.002B	0.00
HCW Biologics (HCWB)	United States	$0.002B	0.00
Abpro Holdings (ABP)	United States	$0.002B	0.00
Ensysce Biosciences (ENSC)	United States	$0.002B	0.00
Onconetix (ONCO)	United States	$0.001B	0.00
Virax Biolabs Group (VRAX)	United Kingdom	$0.001B	0.00
Biodexa Pharmaceuticals (BDRX)	United Kingdom	$0.001B	0.00
NuCana (NCNA)	United Kingdom	$0.000B	0.00
Aceragen (ACGN)	United States	$0.000B	0.00
ARAVIVE, INC (ARAV)	United States	$0.000B	0.00
Compugen (CGEN)	Israel	$0.000B	0.00
Cellectis S.A (CLLS)	France	$0.000B	0.00
Clovis Oncology (CLVSQ)	United States	$0.000B	0.00
Celyad SA (CYAD)	Belgium	$0.000B	0.00
CytoMed Therapeutics (GDTC)	Singapore	$0.000B	0.00
Galapagos (GLPG)	Belgium	$0.000B	0.00
Motif Bio Plc (MTFB)	United Kingdom	$0.000B	0.00
NeuroSense Therapeutics (NRSN)	Israel	$0.000B	0.00
PDL BioPharma (PDLI)	United States	$0.000B	0.00
Pharvaris (PHVS)	Netherlands	$0.000B	0.00
Pulmatrix (PULM)	United States	$0.000B	0.00
TFF Pharmaceuticals (TFFP)	United States	$0.000B	0.00
VectivBio Holding AG (VECT)	Switzerland	$0.000B	0.00